Novolin N
NDC 0169-1834, Human Insulin, injection, suspension, from Novo Nordisk Pharmaceutical Industries, LP.
- Product NDC
- 0169-1834
- Status
- Listed
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN OTC DRUG
- Marketing category
- BLA
- Application
- BLA019959
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1834 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN HUMAN100 [iU]/mL
Pharmacologic classes
Insulin [CS]; Insulin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-1834-02 | 00169183402 | 1 VIAL in 1 CARTON (0169-1834-02) / 10 mL in 1 VIAL |
| 0169-1834-11 | 00169183411 | 1 VIAL in 1 CARTON (0169-1834-11) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 00169183411
GET /v1/drugs/nadac/00169183411
Use it
Look up 0169-1834 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1834 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-1834. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.